| Objective:To explore the changes of serum uric acid levels in patients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD).Methods:45 patients with AECOPD were selected by the revised diagnostic criteria of Chinese Respiratory College in 2007 and exclusion criteria.The patients were separated into three groups according to their FEV1%predicted after the treatment:COPD StageⅡgroup(n= 15),StageⅢgroup(n=15),StageⅣgroup(n=15),control group(n=15).The serum uric acid and PaO2 were detected prior treatment of AECOPD groups;the serum uric acid, PaO2 and FEV1%were detected after clinical remission of the AECOPD groups;the serum uric acid,PaO2 and FEV1%of the control group were detected too.Results:The results of serum UA in patients with AECOPD of the prior treatment:StageⅡgroup(357.87±57.06) umol/L,StageⅢgroup(400.13±51.93)umol/L,StageⅣgroup(483.07±73.65) umol/L, the UA levels of the COPD groups were higher than that of the control group(279.73±43.00) (P<0.05),and there was significant difference between AECOPD groups and control group (P<0.05).The results of serum UA in patients with AECOPD of the post-treatment:StageⅡgroup(316.53±47.16) umol/L,StageⅢgroup(333.33±48.59) umol/L,StageⅣgroup(380.93±44.54)umol/L,After the treatment,the Serum uric acid levels of the three groups decreased signifcantly(P<0.05).The results of PaO2 in patients with AECOPD of the prior treatment:StageⅡgroup(74.27±8.49)mmHg,StageⅢgroup(72.53±6.48) mmHg, StageⅣgroup(50.80±4.00) mmHg,the PaO2 levels of the COPD groups were lower than that of the control group(96.93±2.19)(P<0.05) mmHg,and there wasn't difference between StageⅡgroup and StageⅢgroup(P>0.05),but there was significant difference between StageⅡgroup,StageⅢgroup and StageⅣgroup(P<0.05).The results of PaO2 in patients with AECOPD of the post-treatment:StageⅡgroup(81.27±5.68)mmHg,StageⅢgroup(79.40±6.40)mmHg,StageⅣgroup(58.47±4.88)mmHg,After the treatment the PaO2 levels of the AECOPD groups increased signifcantly(P<0.05).The results of FEV1%in patients with AECOPD of the post-treatment:StageⅡgroup(65.47±9.77%),StageⅢ group(38.47±6.39%),StageⅣgroup(22.00±5.22%),they were all lower than the control group(95.27±3.13%)(P<0.05),the FEV1%in the post-treatment of AECOPD showed significant difference(P<0.05).Conclusion:The serum UA levels of the patients with AECOPD are related to the severity of patient's pathogenetic condition.The measurement of uric acid may serveas a simple and economic indicator of the severity of the patients with COPD. |